Free Trial

Lecap Asset Management Ltd. Acquires Shares of 2,133 Chemed Co. (NYSE:CHE)

Chemed logo with Medical background

Lecap Asset Management Ltd. acquired a new stake in shares of Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,133 shares of the company's stock, valued at approximately $1,130,000.

A number of other institutional investors have also recently added to or reduced their stakes in CHE. State Street Corp raised its holdings in shares of Chemed by 0.8% during the 3rd quarter. State Street Corp now owns 464,354 shares of the company's stock valued at $279,063,000 after purchasing an additional 3,564 shares in the last quarter. Geode Capital Management LLC raised its holdings in Chemed by 4.9% during the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after buying an additional 15,791 shares in the last quarter. Impax Asset Management Group plc lifted its position in shares of Chemed by 4.7% in the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company's stock worth $199,977,000 after buying an additional 14,814 shares during the last quarter. Boston Trust Walden Corp lifted its position in shares of Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after buying an additional 22,105 shares during the last quarter. Finally, FMR LLC boosted its stake in shares of Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company's stock worth $143,401,000 after acquiring an additional 45,917 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently weighed in on CHE. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Saturday, November 30th. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th.

View Our Latest Research Report on CHE

Chemed Stock Performance

Shares of NYSE:CHE traded up $0.32 during midday trading on Tuesday, hitting $553.94. The company's stock had a trading volume of 58,249 shares, compared to its average volume of 91,287. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62. The stock has a market capitalization of $8.34 billion, a price-to-earnings ratio of 27.99, a PEG ratio of 2.16 and a beta of 0.48. The stock's 50 day simple moving average is $542.65 and its 200 day simple moving average is $564.84.

Insiders Place Their Bets

In other news, VP Brian C. Judkins bought 145 shares of the firm's stock in a transaction that occurred on Monday, December 30th. The shares were acquired at an average cost of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company's stock.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines